SEPN Septerna, Inc.: Nilai pasar

Simbol resmi perusahaan Septerna Pharma (SEPN)

Septerna Inc (SEPN) develops drugs for cellular receptors, focusing on immune and endocrine pathologies. This price chart demonstrates the asset's market dynamics, where the capitalization stands at 1.86. The business relies on immense scaling potential: following costly research, patents enable the generation of colossal profits. Meanwhile, a neutral political climate and the humanitarian status of the developments minimize external risks for the company.

SEPN Septerna: Kapitalisasi pasar ing interval 26.10.2024 - 22.10.2026

Rincian metrik komprehensif lan analitis Septerna Pharma (SEPN)

Indikator keuangan lan pasar perusahaan Septerna Inc (SEPN):
Analisis fundamental perusahaan:SEPN (Septerna)
Sampel barang Septerna Pharma

The innovative potential of Septerna Inc (SEPN) in receptor technologies is directly reflected in its market capitalization, calculated as the product of the current share price and the total number of outstanding securities. This metric measures the aggregate market value of the business, allowing investors to assess the scale of the enterprise and promptly identify signs of asset overheating or financial instability through the company's capitalization chart.

Pesaing wigati

Kapitalisasi pasar ARGX (argenx)|BioNTech Inc. (BNTX) - Nilai pasar|ABVX - Nilai pasar|Biji pasar ADMA|Protagonist Therapeutics (PTGX) - Nilai pasar|Kapitalisasi pasar IMVT|Nilai pasar Kiniksa|Grifols SA - Biji pasar|Kapitalisasi pasar ADPT|CLDX (Celldex Corp) - Nilai pasar|Kapitalisasi pasar AUPH (Aurinia Pharmaceuticals)|Kapitalisasi pasar biocryst.com BCRX|VERA - Nilai pasar|Nilai pasar DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Nilai pasar|Biji pasar AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar precigen.com|Biji pasar PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Nilai pasar|Kapitalisasi pasar UPB (Upstream Bio Corp)|Kapitalisasi pasar Zenas Corp (ZBIO)|IMNM - Nilai pasar|gossamerbio.com (GOSS) - Biji pasar|KalVista Pharmaceuticals, Inc. (KALV) - Nilai pasar|Biji pasar Pieris Pharma|Biji pasar SVRA|Kapitalisasi pasar Rigel Corp|Nilai pasar AnaptysBio, Inc. (ANAB)|astriatx.com - Kapitalisasi pasar|Kapitalisasi pasar ENGN (enGene)|rapt.com (RAPT) - Nilai pasar|JBIO - Nilai pasar|Kapitalisasi pasar Aclaris Therapeutics, Inc ACRS|KYTX: Kapitalisasi pasar|Nilai pasar tizianalifesciences.com (TLSA)|Nilai pasar Cabaletta Bio|Ventyx Biosciences Inc. - Biji pasar|Biji pasar THTX (Theratechnologies Inc)|Nilai pasar AVTX|Kapitalisasi pasar ELDN (Eledon Pharmaceuticals)|agenusbio.com (AGEN) - Nilai pasar|CLYM - Nilai pasar|Nilai pasar ZURA (zurabio.com)|aTyr (ATYR) - Nilai pasar|Kapitalisasi pasar ADAG|IMA (ImageneBio) - Kapitalisasi pasar|Kapitalisasi pasar Shattuck Therapeutics|Biji pasar EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Nilai pasar|Kapitalisasi pasar IMUX (Immunic)|Kapitalisasi pasar Atara Biotherapeutics, Inc. (ATRA)|IFRX - Nilai pasar|XFOR (x4pharma.com) - Kapitalisasi pasar|ACET: Kapitalisasi pasar|Biji pasar Celularity|Nilai pasar INmune Bio Corp|Barinthus Biotherapeutics Corp (BRNS) - Kapitalisasi pasar|Kapitalisasi pasar KZR|SABS - Nilai pasar|Nilai pasar Akari Therapeutics Plc AKTX|ENLV (Enlivex Therapeutics Ltd) - Biji pasar|QTTB - Nilai pasar|GOVX (GeoVax Corp) - Kapitalisasi pasar|Edesa Biotech, Inc. (EDSA) - Nilai pasar|Biji pasar IBIO (ibioinc.com)|CARM (Carisma Therapeutics Inc) - Kapitalisasi pasar|XTLB: Nilai pasar|Kapitalisasi pasar BOLT|Kapitalisasi pasar hcwbiologics.com (HCWB)|Nilai pasar Aptevo Therapeutics Inc. APVO|Nilai pasar AIM|ADTX - Nilai pasar|GRI Bio Inc (GRI) - Biji pasar|XRTX: Kapitalisasi pasar|Vyome Therapeutics (HIND) - Kapitalisasi pasar|Biji pasar REVB|INDP: Nilai pasar|Kapitalisasi pasar SCNI|Kapitalisasi pasar calcimedica.com|Nilai pasar Affimed N.V. AFMD|ALLK - Biji pasar|HOOK - Nilai pasar|IGM Biosciences, Inc. (IGMS) - Biji pasar|ITOS (iTeos Therapeutics, Inc.) - Biji pasar|Ocean Biomedical Inc (OCEA) - Kapitalisasi pasar|Nilai pasar TC BioPharm (Holdings) PLC|Kapitalisasi pasar THRD (Third Harmonic Bio Inc)